… , in absence of vaccines and drugs. The pathogenesis of SARS-CoV-2 is still being elucidated.
Identifying potential targets and repurposing drugs as therapeutic options is the need of …

… drugs, and it can be accomplished by repurposing drugs that are discussed in this article. In
this review, first, we will discuss drugs … In the next section, we will focus on the drugs that are …

… we screen a repurposing library of ∼3,000 drugs. Screening … validates 23 diverse antiviral
drugs. Extending our studies to … in drug sensitivity and entry pathways used by SARS-CoV-2 in …

… drugs are included 3CL protein inhibitors, RNA synthesis inhibitors and other small molecule
drugs which target the ability of SARS-COV… how some repurposed antiviral drugs, indicated …

… drug discovery against this disease. We explore the prevalence of this confound in SARS-CoV-2
repurposing … hits rapidly so as to focus on drugs with genuine potential against COVID-…

… here supports those drugs as feasible alternatives to face the SARS-CoV infection in the
short term, whereas more effective measures arise from the world scientific community. …

… In this comparative review, we focus on repurposed drugs with antiviral effects against
SARS‐CoV‐2 in cell‐based assays as those substances offer great opportunities for a treatment …

… drugs that specifically target SARS-CoV-2. Until an effective vaccine is available, repurposing
FDA approved drugs … reduce the cost compared to de novo drug discovery. In this study we …

… that either were effective in inhibiting SARS-CoV-2 in vitro or displayed some … human
coronavirus infections. Here, we discuss the results obtained with some of the repurposed drugs …

… The drug repurposing for SARS-CoV-2 is discussed in detail along with … SARS-CoV-2
with reference to case studies. The ongoing clinical trials both with respect to drug repurposing …